GlassScriptPhysician profile
Shellie A Green
NPI 1124636113
$362.63
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $56.99 · 2023: $207 · 2024: $98.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $305.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $59.01 | 2022-2023 | |
| Daiichi Sankyo INC. | $49.99 | 2023 | Injectafer |
| Pfizer INC. | $49.25 | 2023-2024 | |
| Novo Nordisk INC | $41.23 | 2023-2024 | Wegovy |
| Pacira Pharmaceuticals Incorporated | $38.16 | 2022 | |
| Organon LLC | $25.93 | 2023 | Nexplanon |
| Astellas Pharma US INC | $25.67 | 2024 | Veozah |
| Sumitomo Pharma America, INC. | $24.59 | 2023 | Myfembree |
| Shield Therapeutics INC | $18.53 | 2023 | Accrufer |
| Lilly USA, LLC | $16.85 | 2024 | Zepbound, Jardiance |
| Merck Sharp & Dohme LLC | $13.42 | 2024 | Gardasil, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shellie Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.